The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (Review)

Anticancer Research

Volumn 17, Issue 1 B, 1997, Pages 657-662

  Strang, Peter ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anorexia; Cachexia; Megestrol acetate; Nausea; Quality of life; Weight gain

Indexed keywords

CORTICOSTEROID; CYPROHEPTADINE; MEGESTROL ACETATE; METOCLOPRAMIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANOREXIA; APPETITE; BODY FAT; BODY IMAGE; BODY WEIGHT DISORDER; CACHEXIA; CANCER PATIENT; CLINICAL TRIAL; DRUG COST; EDEMA; FATIGUE; HUMAN; LIFE EXPECTANCY; MOOD; NAUSEA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; THROMBOEMBOLISM; WEIGHT GAIN; WEIGHT REDUCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANOREXIA; APPETITE STIMULANTS; CACHEXIA; DOUBLE-BLIND METHOD; HUMANS; MEGESTROL ACETATE; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; WEIGHT LOSS;

EID: 0031052671     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Bruera E, Fansinger R: Clinical management of cachexia and anorexia. In: D Doyle, G Hanks, N MacDonald (eds). Oxford textbook of palliative medicine. Oxford Med Publ, Oxford 1943. pp. 330-337.
2. Jwestin T, Edstrom S, Lundholm K: Tumor cell proliferation and nutrition. Am J Clin Nut 53: 764-768, 1991.
3. Alexander HR, Norton J: Pathophysiology of cancer cachexia. In: D Doyle, G Hanks, N MacDonald (eds). Oxford textbook of palliative medicine. Oxford Med Publ, Oxford pp 316-329, 1993.
4. Svaninger G, Bennegard K, Ekman L, Ternell M, Lundholm K: Lack of evidence for elevated breakdown rate of skeletal muscles in weight-losing tumorbearing mice. JNCI 71: 341-346, 1983.
5. Langstein H, Fraker D, Norton J: Reversal of cancer cachexia by antibodies to inierferon-gamma but not to cachectin/tumor necosis factor. Surg Forum 15: 408-410, 1989.
6. Sherry B, Gelin J, Fong Y et al: Anticachectin/tumor necrosis factor-alfa antibodies attenuate development of cachexia in tumor models, FASEB Journal 3: 1956-1962, 1989.
7. Gelin. J Moldawer L, Lönnroth C, Sherry B, Chizzonite R, Lundholm K: The role of endogenous TNF-alfa and interleukin-1 for experimental tumor growth and the development of cancer cachexia. Cancer Res 51: 415-421, 1991.
8. Mantovani G, Maccio A, Curreli L et al: Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy. Int J Clin Lab Res 25(3): 135-141, 1995.
9. Amadorí D, Maltoni M, Fabbri L et al: Biological and clinical correlations in cancer cachexia - the pathophysiology of cachexia, 4th Congress of the EAPC. Barcelona. Spain Dec 1995. Eur J Palliat Care 1995, Abstract supplement.
10. Koretz R: Parenteral nutrition: is it oncologically logical? J Clin Oncol 2: 534-538, 1984.
11. Hyltander A, Drott C, Unsgaard B et al: The effect on body composition and exercise performance of home parenteral nutrition when given as adjunct to chemotherapy of testicular carcinoma. Eur J Clin Invest 21: 413-420, 1991.
12. Schulzc-Delriev K: Metochlopramide. New Engl J Med 305: 28-32, 1981.
13. Popiela T, Lucchi R, Giongo F: Methylprednisolone as palliative therapy for female terminal cancer patients. Eur J Cancer Clin Oncol 25: 1823-1829, 1989.
14. Brucra E, Roca E, Cedaro L et al: Action of oral methyl prednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 69: 751-754, 1985.
15. Kardinal C, Loprinzi C Shaid D et al: A controlled trial of cyproheptadine in cancer patients with anorexia. Cancer 1990, 65: 2657-2662, 1990.
16. Huges T et al: Modulation of tumor necrosis factor activities by potential anticachexia compound hydrazine sulfate. Int J Immunopharmacol 11: 501-507, 1989.
17. Hengge U, Baumann M, Malessa R, Brockmeyer N, Goos M: Oxymetholone promotes weight gain in patients with advanced human immunodefiency virus (HIV1) infection. Br J Nutr 75: 129-138, 1996.
18. McCarthy H, Crowder R, Dryden S, Williams C: Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations, Eur J Pharmacol 265 (1-2): 99-102, 1994.
19. Loprinzi C, Ellison N, Schaid D et al: Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. JNCI 82: 1127-1132, 1990.
20. Bruera E, MacMillan K, Kuehn N, Hanson J, MacDonald N: A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status and other symptoms in patients with advanced cancer, Cancer 66: 1279-1282, 1990.
21. Tchekmedyian N, Hickman M, Siau J et al: Megestrol acetate in cancer anorexia and weight loss. Cancer 69: 1268-1274, 1992.
22. Schmoll B: Risks and benefits of various therapies for cancer cachexia. Oncology 40 (suppl 2): 43-45, 1942.
23. Feliu J, Gonzalez-Baron M, Berrocal A et al: Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study. Am J Clin Oncol 15: 436-440, 1992.
24. Loprinzi C, Michalak J, Schaid D et al: Phase 11 evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and or cachexia. J Clin Oncol 11: 762-767, 1993.
25. HeCOG (Hellenic co-operative oncology group/ Skarlos et al): Megestrol acetate in cancer patients with anorexia and weight loss, Acta Oncol 32: 37-41, 1993.
26. Bruntzel J, Kuttner K: Stellung des megestrolacetates in der behandlung der kachexie bei kopf-hals tumoren. Laryngo-Rhino- Otologie 74: 504-507, 1995.
27. Veenhof C, van der Burg M, Nooy et al: Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinoma. Eur J Cancer 30A: 697-698, 1994.
28. Kornblith A, Hollis D, Zuckerman E et al: Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. J Clin Oncol 21: 2081-2089, 1993.
29. Heckmayr M, Gatzemeier U: Treatment of cancer weight loss in patients with advanced lung cancer. Oncology 49 (suppl 2): 32-34, 1992.
30. Mantovani G, Maccio A, Bianchi A et al: Megestrol acetate in neoplastic anorexia / cachexia: clinical evaluation and comparison with cytokine levels in patients with head neck carcinoma treated with neoadjuvant chemotherapy, Int J Clin Lab Res 25: 135-141, 1995.
31. Rowland K Jr, Loprinzi C, Shaw E et al: Randomised double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate / placebo in extensive-stage small-cell cancer: a North Central Cancer Treatment Group study. J Clin Oncol 14: 135-141, 1996.
32. Lai Y, Fang F, Yeh C: Management of anorexic patients in radiotherapy: a prospective randomized comparison of megestrol and prednisolone J Pain Symptom Manage 9: 265-268, 1994.
33. Oster M, Enders S, Samuels S et al: Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med 121: 400-408, 1994. ( + commenting letters 122: 879-881, 1994)
34. von Roenn J, Armstrong D, Kotler D et al: Megestrol acetate in patients with AIDS-related cachexia, Ann Intern med 121: 393-399, 1994. (+ commenting letters 122: 879-881, 1994).
35. Loprinzi C, Schaid D, Dose A, Burnham N, Jensen M: Body-composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol 11: 152-154, 1993.
36. Cella, D, VonRoen J, Lloyd S, Browder H: The Bristol-Myers anorexia / cachexia recovery instrument (BACRI): a brief assessment of patients' subjective response to treatment for anorexia / cachexia, Quality of Life Res 4: 221-231, 1995.